Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)
ID: 353669Type: Forecasted
Overview

Buyer

Agency for International Development (USAID)

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Other

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353669
Timeline
    Description

    The United States Agency for International Development (USAID) is seeking expert insights through a Request for Information (RFI) aimed at accelerating HIV vaccine research and development in low- and middle-income countries (LMIC). The RFI invites recommendations on five key areas: fostering a collaborative research environment in Africa, streamlining the manufacturing of HIV vaccine candidates, assessing the safety of an antibody cocktail for infants, innovating new protective methods, and enhancing community engagement in vaccine research. This initiative is crucial for addressing the ongoing challenges of HIV in LMICs and promoting local leadership and equitable partnerships in vaccine development. Interested parties must submit their responses electronically by May 24, 2024, to Simone Cho at scho@usaid.gov, adhering to the specified submission guidelines.

    Point(s) of Contact
    Simone Cho Grantor
    (202) 916-2729
    scho@usaid.gov
    Files
    Title
    Posted
    _RFI - Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries.pdf
    Amendment.pdf
    The United States Agency for International Development (USAID) has issued Amendment 1 to Request for Information (RFI) number 7200AA24RFI00017, dated April 22, 2024, regarding HIV vaccine research and development in low- and middle-income countries (LMIC). The RFI seeks expert insights to aid in planning future initiatives aimed at enhancing HIV vaccine development, though it neither constitutes a funding opportunity nor a formal request for proposals. Interested parties are encouraged to provide their recommendations relating to five key areas: fostering a collaborative research environment in Africa, streamlining the manufacturing of HIV vaccine candidates, assessing the safety of an antibody cocktail for infants, innovating new protective methods, and bolstering community engagement in vaccine research. Additional opportunities and challenges in HIV vaccine development, particularly those that promote local leadership and equitable partnerships, are also invited for consideration. Submissions should be electronically sent by May 24, 2024, adhering to specified guidelines. This RFI represents USAID's commitment to gathering diverse perspectives to effectively address HIV challenges in LMICs.
    Similar Opportunities
    HIV/AIDS Activities
    Active
    Burundi USAID-Bujumbura
    The United States Agency for International Development (USAID) in Burundi is seeking innovative ideas and strategies to enhance its HIV/AIDS programming through a Request for Information (RFI) issued on March 17, 2022. The primary objective of this RFI is to gather insights on addressing gaps and challenges in the HIV response in Burundi, particularly focusing on clinical programming, community involvement, treatment interruptions, and the needs of orphans and vulnerable children. This initiative is crucial for improving the effectiveness and equity of HIV services in alignment with global health initiatives, emphasizing the importance of community participation in achieving epidemic control. Interested parties can submit their responses electronically by March 31, 2022, to Liliane Gatunange at lgatunange@usaid.gov, with no individual feedback provided to respondents.
    Request for Information- Building Resilience amongst Families affected with HIV Activity
    Active
    Dominican Republic USAID-Santo Domingo
    The United States Agency for International Development (USAID) is issuing a Request for Information (RFI) to gather insights for a proposed five-year program aimed at improving health, education, and socioeconomic outcomes for vulnerable children, adolescents, and families of Haitian descent in the Dominican Republic affected by HIV. The program's objectives include achieving epidemic control and reducing HIV transmission through a comprehensive case management approach that links families to essential health and social services, while also addressing stigma and enhancing access to care. Interested parties, including local stakeholders and organizations, are invited to submit their feedback by March 1, 2022, at 4:00 PM EST, with responses to be sent via email to designated USAID contacts. This initiative aligns with USAID's broader goals in combating HIV/AIDS and is categorized under discretionary funding with no cost-sharing requirements.
    New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is inviting applications for the New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE), aimed at accelerating the development of a safe and effective HIV vaccine through collaborative research led by African scientists and institutions. This funding opportunity includes at least two cooperative agreements, with a total funding ceiling of $98.5 million over five years, structured around two main objectives: enhancing African-led clinical research and advancing promising immunogens towards first-in-human studies. The program emphasizes innovative, locally-led approaches and is open to a wide range of eligible applicants, including nonprofits without 501(c)(3) status, with a focus on projects predominantly within African countries to leverage local capabilities in addressing global HIV vaccine research challenges. Interested parties must submit a concept paper by January 28, 2025, and can contact Elton Fortson at npithrive@usaid.gov for further information regarding the application process.
    RFI- Zambia Integrated HIV and Health Activity (ZIHA)
    Active
    Zambia USAID-Lusaka
    The United States Agency for International Development (USAID) is seeking feedback from non-governmental organizations regarding the "USAID Zambia Integrated HIV and Health Activity," aimed at enhancing sustainable HIV/AIDS prevention, care, treatment services, and maternal, newborn, and child health (MNCH) services in Zambia's Central, Copperbelt, and Northwestern Provinces. The primary objective is to gather insights on organizations' capacities to support USAID and PEPFAR's 95/95/95 goals and to improve the integration of health services for better client-centered outcomes. This Request for Information (RFI) is crucial for refining the activity design, with a potential solicitation expected in early Fiscal Year 2022. Interested parties should submit their responses by August 19, 2021, via email to oaa-solicit-lusaka@usaid.gov, ensuring confidentiality of the information provided.
    Support to Zimbabwe's Programs for HIV prevention, Care and Treatment
    Active
    Zimbabwe USAID-Harare
    The United States Agency for International Development (USAID) is forecasting a Request for Information (RFI) to gather insights for future funding opportunities aimed at supporting HIV prevention, care, and treatment programs in Zimbabwe. The RFI seeks to engage local organizations with expertise in HIV program management to provide strategic input for two anticipated Requests for Applications (RFA): Program A, which focuses on enhancing comprehensive health services for HIV-positive individuals and high-risk populations, and Program B, which aims to prevent new infections among adolescent girls and young women through the DREAMS initiative. This initiative is crucial for addressing the multi-sectoral HIV response led by the Government of Zimbabwe. Interested organizations are encouraged to submit their responses, which should include organizational background and program interest, to J. Zeb Simpson at jsimpson@usaid.gov by the specified deadlines. The RFI does not guarantee funding and is intended solely for market research purposes.
    RFI - - Regional Implementation Science (IS) Research for Improved Sexual and Reproductive Health (SRH) Programs
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) has issued a Request for Information (RFI) to gather insights for the design of a new Regional Implementation Science Research initiative aimed at improving Sexual and Reproductive Health (SRH) programs in West, Central, East, and Southern Africa. This RFI seeks input from local entities to refine research priorities, emphasizing local ownership and the strategic context necessary to address both local and global SRH challenges. The initiative aligns with USAID's commitment to implementation science and aims to generate evidence to enhance SRH service access and utilization through data-driven practices. Interested parties are encouraged to submit their responses via the provided Google Forms by August 13, 2024, at 5:00 AM EDT, and can direct inquiries to Safaa Abdelrahim at sabdelrahim@usaid.gov or by phone at 202-430-4998.
    Microbicides Research, Development, and Introduction
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    South Africa Health Financing Activity
    Active
    South Africa USAID-Pretoria
    The United States Agency for International Development (USAID) is inviting interested parties to participate in a Request for Information (RFI) regarding a prospective five-year Health Financing Activity aimed at enhancing health financing systems in South Africa. The RFI seeks evidence-based suggestions to address challenges related to domestic resource mobilization for health, particularly in the context of HIV, TB, and COVID-19 responses, as well as strategies for human resource financing and effective health financing models. This initiative is crucial for improving governance, implementing health technology assessments, and facilitating data-driven budget planning to align with South Africa's national health objectives. Responses to the RFI must be submitted by September 2, 2022, and interested parties can contact Boitumelo P Mahlomoje at bmahlomoje@usaid.gov or by phone at 0124522000 for further information.
    Sources Sought Notice for HIV Affected Orphans and Vulnerable Children (OVC) and Adolescent Girls and Young Women (AGYW)
    Active
    Haiti USAID-Port Au Prince
    The U.S. Agency for International Development (USAID) is issuing a Sources Sought Notice (SSN) to identify potential local and international partners for an initiative aimed at supporting HIV-affected Orphans and Vulnerable Children (OVC) and Adolescent Girls and Young Women (AGYW) in Haiti. Interested organizations are required to submit their responses by August 1, 2023, detailing their capabilities and relevant experience, particularly emphasizing local entities registered in Haiti. This initiative builds upon USAID’s previous efforts under the Impact Youth initiative and aligns with the Reimagine PEPFAR Strategic Direction Initiative, focusing on community-based support that includes education, psychosocial services, economic empowerment, and health access for vulnerable populations. For further inquiries, interested parties can contact Sandra Ricot, Acquisition Specialist, at sricot@usaid.gov or by phone at 509-2229-8569.
    Strengthening Medical Product Quality Assurance (QA) Systems Activity Market Research, Bureau for Global Health
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is seeking input through a Request for Information (RFI) aimed at strengthening medical product Quality Assurance (QA) systems in low- and middle-income countries (LMICs). The RFI, numbered 7200AA23RFI00015, invites responses that address barriers, opportunities, and innovations in medical product QA systems, with a focus on regulatory system strengthening, local capacity building, and sustainable pharmaceutical market growth. This initiative is crucial for enhancing the efficacy of medical products and improving health outcomes globally. Interested parties must submit their responses electronically by October 13, 2023, to ohsmarketresearch@usaid.gov, adhering to specified formatting requirements. For further inquiries, contact Imran Mahmud at imahmud@usaid.gov.